Pnc Financial Services Group, Inc. Cytek Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,816 shares of CTKB stock, worth $12,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,816
Previous 8,850
56.88%
Holding current value
$12,592
Previous $57,000
73.68%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CTKB
# of Institutions
160Shares Held
73.8MCall Options Held
600Put Options Held
4.9K-
Black Rock Inc. New York, NY17.1MShares$56.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.62MShares$31.8 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.46MShares$24.6 Million0.93% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$22 Million0.82% of portfolio
-
State Street Corp Boston, MA4.38MShares$14.5 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $444M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...